🇮🇱 Israel Country × Condition
carcinoma non small cell lung Clinical Trials in Israel
Active clinical trials for carcinoma non small cell lung with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇮🇱 Israel
Active Trials in Israel (2)
NCT04165798
Recruiting
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Enrollment
1,065 pts
Country
🇮🇱 Israel
Merck Sharp & Dohme LLC
View Trial → NCT04165070 Phase 1, Phase 2
Recruiting
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Enrollment
450 pts
Country
🇮🇱 Israel
Merck Sharp & Dohme LLC
View Trial → Frequently Asked Questions
How many carcinoma non small cell lung clinical trials are active in Israel?
There are currently 2 active clinical trials for carcinoma non small cell lung with sites in Israel, of which 2 are actively recruiting patients.
How can I join a carcinoma non small cell lung clinical trial in Israel?
To join a carcinoma non small cell lung clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are carcinoma non small cell lung trials in Israel?
Active carcinoma non small cell lung trials in Israel span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology